HELICON Trademark

Trademark Overview

On Friday, November 15, 2019, a trademark application was filed for HELICON with the United States Patent and Trademark Office. The USPTO has given the HELICON trademark a serial number of 88693700. The federal status of this trademark filing is REGISTERED as of Tuesday, November 14, 2023. This trademark is owned by Fog Pharmaceuticals, Inc.. The HELICON trademark is filed in the Pharmaceutical Products category with the following description:

Biomedical compounds for medical purposes, namely, peptides, stapled peptides, and synthetic peptides, all comprised of amino acids, for the treatment of cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions; biomedical compounds for medical purposes, namely, miniproteins, and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions
helicon

General Information

Serial Number88693700
Word MarkHELICON
Filing DateFriday, November 15, 2019
Status700 - REGISTERED
Status DateTuesday, November 14, 2023
Registration Number7219023
Registration DateTuesday, November 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2020

Trademark Statements

Goods and ServicesBiomedical compounds for medical purposes, namely, peptides, stapled peptides, and synthetic peptides, all comprised of amino acids, for the treatment of cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions; biomedical compounds for medical purposes, namely, miniproteins, and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 21, 2019
Primary Code005
First Use Anywhere DateMonday, May 22, 2023
First Use In Commerce DateMonday, May 22, 2023

Trademark Owner History

Party NameFog Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameFog Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameFog Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Tuesday, November 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 14, 2023REGISTERED-PRINCIPAL REGISTER
Friday, October 13, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 12, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 12, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, October 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 12, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, October 12, 2023SU-EXAMINER'S AMENDMENT WRITTEN
Wednesday, August 23, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 23, 2023NON-FINAL ACTION E-MAILED
Wednesday, August 23, 2023SU - NON-FINAL ACTION - WRITTEN
Thursday, August 10, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, August 7, 2023USE AMENDMENT FILED
Monday, August 7, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, February 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 8, 2023SOU EXTENSION 5 GRANTED
Monday, January 23, 2023SOU EXTENSION 5 FILED
Wednesday, February 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 23, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 8, 2022SOU EXTENSION 4 GRANTED
Friday, July 8, 2022SOU EXTENSION 4 FILED
Friday, July 8, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 15, 2022SOU EXTENSION 3 GRANTED
Tuesday, February 15, 2022SOU EXTENSION 3 FILED
Tuesday, February 15, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 3, 2021SOU EXTENSION 2 GRANTED
Tuesday, August 3, 2021SOU EXTENSION 2 FILED
Tuesday, August 3, 2021SOU TEAS EXTENSION RECEIVED
Friday, February 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021SOU EXTENSION 1 GRANTED
Wednesday, February 10, 2021SOU EXTENSION 1 FILED
Wednesday, February 10, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NON-FINAL ACTION WRITTEN
Wednesday, February 19, 2020ASSIGNED TO EXAMINER
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 19, 2019NEW APPLICATION ENTERED

Related Keywords

helicon conditions peptides immunological miniproteins biomedical disorders cardiovascular diseases infectious cancer